Understand the source comparison
KPV Autoimmune Research Mechanism: KPV vs Traditional Anti-Inflammatory Peptides
KPV MC-1R agonism → NF-κB cytoplasmic retention Melanocortin-1 receptor Direct (prevents translocation) 50–60% reduction Minimal T-cell suppression Most selective innate immune modulator. Preserves adaptive responses α-MSH Broad melanocortin receptor activatio
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- KPV
- MC-1R agonism → NF-κB cytoplasmic retention
- Melanocortin-1 receptor
- Direct (prevents translocation)
- 50–60% reduction
- Minimal T-cell suppression
- Most selective innate immune modulator. Preserves adaptive responses
- α-MSH
- Broad melanocortin receptor activation
- MC-1R, MC-3R, MC-4R, MC-5R
- Indirect (via cAMP/PKA)
- 55–65% reduction
- Moderate T-reg enhancement
- Broader anti-inflammatory effect but less receptor specificity
- LL-37
- Membrane disruption + TLR modulation
- Multiple (non-receptor-mediated)
- Minimal
- 30–40% reduction
- Variable (can enhance or suppress)
- Antimicrobial-dominant with secondary immune effects
- Thymosin β4
- Actin sequestration + wound healing
- Non-receptor (cytoskeletal)
- None
- 20–30% reduction
- Promotes T-cell maturation
- Tissue repair focus. Weak direct anti-inflammatory action